Novartis Drug Gilenya Shows Significant Early Effect on Reducing Brain Volume …
Novartis drug Gilenya shows significant early effect on reducing brain volume …
Filed under: drug treatment news 2010
Vol.362 No.5, Feb 4, 2010;362:402-415.7.Havrdov¡ E. et al. Clinical outcomes in subgroups of patients with highly action relapsing-remitting multiple sclerosis treated with Fingolimod (FTY720): Results from the FREEDOMS and TRANSFORMS phase III …
Read more on MENAFN.COM
Could 'miracle drug' be answer to fight heroin addiction?
Filed under: drug treatment news 2010
Vivitrol was approved in October 2010 by the Food and Drug Administration for the treatment of opioid dependence. Experts say it could be a game-changer in combating the increasing abuse of oxycodone and other prescription painkillers, which doctors …
Read more on Philadelphia Inquirer
Addiction plays role in state's deadly diagnosis
Filed under: drug treatment news 2010
In fact, a 2012 report from the West Virginia Department of Health and Human Resources states prescription drug overdoses increased from 2001-2010. The Centers for Disease Control and Prevention showed the Mountain State had the second highest rate …
Read more on State Journal
More drug treatment news 2010 Resources
New Analysis Indicates That Novartis Drug Gilenya Shows Significant Early Effect On Reducing Brain Volume Loss At 6 …New analysis of two large Phase III studies demonstrates a significant early treatment effect of Gilenya on relapses and MRI outcomes, including brain volume loss, in MS patients Data show generally higher … Read News
Gilenya Shows Significant Early Effect On Lowering Brain Volume Loss At 6 MonthsGilenya Shows Significant Early Effect On Lowering Brain Volume Loss At 6 Months … Read News